Trending News

News round-up by DDW’s Megan Thomas for 11-15 October   For this week’s drug discovery round up, DDW’s Megan Thomas has selected five stories that showcase how organisations and collaboration within the drug discovery industry can provide researchers and drug developers with the tools they need to move forward with life-saving treatments.   Therapeutics research partnership to access induced […]

The Fall Issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & ELRIG UK supplement ahead of ELRIG UK’s Drug Discovery 2021 in Liverpool, October 19-20, 2021. In it, ELRIG UK’s General Manager Sanj Kumar welcomes the event and introduces the themes.   In 2019, ELRIG’s flagship scientific conference, Drug Discovery, attracted over […]

Scientists revealed in a new study how gut bacteria contribute to the progression of advanced prostate cancers and their resistance to hormone therapy by providing an alternative source of growth-promoting androgens, or male hormones.  Hormone therapy is the standard of care for advanced prostate cancer and works by lowering levels of androgens. But researchers found […]

The Fall Issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & ELRIG UK supplement ahead of ELRIG UK’s Drug Discovery 2021 in Liverpool, October 19-20, 2021. DDW Editor Lu Rahman welcomes the event and introduces the themes.   To say that I – as well as the entire DDW team – am excited […]

The World Health Organization (WHO) has recommended GlaxoSmithKline (GSK)’s RTS,S malaria vaccine to be given to children living in sub-Saharan Africa who are at risk of contracting Malaria.  RTS,S is the first and only malaria vaccine to have been shown in pivotal long-term clinical trials to significantly reduce malaria in children. The vaccine is the result […]

News round-up by DDW’s Megan Thomas for 4-8 October  For this week’s drug discovery round up, DDW’s Megan Thomas focuses on stories that provide answers to previously unanswered questions, or news that enables researchers and scientists to find those answers quickly.  1. Novel therapy could be effective against paediatric leukaemia  Mount Sinai researchers have developed […]

AlzeCure Pharma has dosed the first patient in the company’s next clinical Phase I study (multiple ascending dose, MAD) with the candidate drug ACD856, focused on Alzheimer’s disease. ”It is satisfying that the clinical development program is proceeding according to plan and that we have now begun this follow-up Phase I study where we will […]

The Fall Issue of the Drug Discovery World Magazine is out now. Featuring Insight Into China’s Drug Discovery Landscape, the magazine is available to download and read for free on the DDW App.  Key features of the Fall Issue include “LIMs vs ELNs – what does your lab need”, expert insight on engineering antibodies and a focus on clinical trials, plus […]

If authorised, molnupiravir could be the first oral antiviral medicine for Covid-19. Merck (known as MSD outside the United States and Canada) and Ridgeback Biotherapeutics have announced that molnupiravir, an investigational oral antiviral medicine, significantly reduced the risk of hospitalisation or death at a planned interim analysis of the Phase III MOVe-OUT trial in at […]

Researchers have discovered a potential advancement in the treatment of chronic myeloid leukaemia (CML), which they hope will one day offer an improved option for treating patients with this form of blood cancer. The study– published in Science Translational Medicine and led by the University of Glasgow in collaboration with LifeArc – has discovered a […]